BSE filing, NSE: HIKAL. Summary written from the filing by ALFA Finder's alert engine.
Hikal Ltd: key numbers
- Share price
- ₹204.40
- Market cap
- ₹2,520 Cr
- Revenue (annual)
- ₹1,713 Cr
- Net profit (annual)
- ₹-48.80 Cr
- P/E (TTM)
- -74.6×Sector 48.7×
- Promoter holding
- 68.85%+0.00% QoQ
- FII holding
- 1.28%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Hikal Ltd
All →Hikal Regulatory Approval
Hikal's Bengaluru API facility received a Swissmedic GMP Certificate of Compliance. The certification supports wider access to European and other regulated markets.
Hikal Other Announcement
Hikal Ltd filed its quarterly shareholding pattern for the period ended 30 September 2026. The filing reports routine ownership data with no new transaction.
Hikal Board Meeting Date
Hikal's board meets November 3, 2026 to consider September quarter and half-year results. The results are yet to be approved.
Hikal Other Announcement
Hikal Ltd filed its quarterly shareholding pattern for the period ending September 30, 2026, as required under SEBI Regulation 31(1)(b).
Hikal Management Change
Hikal Limited announced the cessation of Mr. Jai Hiremath as Executive Chairman and the resignation of Mrs. Sugandha Hiremath. Mr. Anish Swadi was appointed as CEO-Animal Health.
Hikal Other Announcement
Hikal Ltd. has been assigned an ESG rating of "Crisil ESG 65" by Crisil ESG Ratings & Analytics Limited, based on their independent assessment of public data.
Other board meeting date announcements
All →Veer Energy & Infrastructure Board Meeting Date
Veer Energy & Infrastructure Ltd intimated its Board meeting on 14 Nov 2026 to consider Q1/H1 results. Trading window reopens 17 Nov 2026.
M & B Engineering Board Meeting Date
M&B Engineering schedules a board meeting on 5 Nov 2026 to consider and approve unaudited financial results for Q1 and H1 FY27. No results or financial figures are disclosed in this intimation.
Allcargo Terminals Board Meeting Date
Allcargo Terminals scheduled a board meeting for 4 Nov 2026 to approve Q1/H1 FY27 financial results. The trading window remains closed until 6 Nov 2026.
Gillanders Arbuthnot & Company Board Meeting Date
Gillanders Arbuthnot scheduled its board meeting for 13 November 2026 to approve Q2/H1 FY27 results. No decisions or figures have been announced yet.
Windlas Biotech Board Meeting Date
Windlas Biotech intimated that its Board meeting is scheduled for 5 November 2026 to consider unaudited standalone results for Q1 FY27. No monetary figure is disclosed in this advance notice.
TARC Board Meeting Date
TARC Ltd intimated that its Board will meet on 5 Nov 2026. The agenda includes approving unaudited H1 FY27 financial results.